Renal cell carcinoma is a heterogeneous disease, and tissue investigations provide clues that may predict treatment response. Oncogenomic analysis of five outliers, who achieved a sustained response with rapalogs, implicates alterations of the TSC1 and mTOR genes and reveals insights into the conserved evolution of tumors. ©2014 AACR.
CITATION STYLE
Chism, D. D., & Rathmell, W. K. (2014). Seeing the forest for the trees: Kidney oncogenomes in relation to therapeutic outcomes. Clinical Cancer Research, 20(7), 1721–1723. https://doi.org/10.1158/1078-0432.CCR-14-0056
Mendeley helps you to discover research relevant for your work.